Perspecta revenue was $4.50 b in FY, 2020 which is a 11.8% year over year increase from the previous period.
Perspecta revenue breakdown by business segment: 68.8% from Defense and Intelligence and 31.2% from Civilian and Health Care
USD | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|
Revenue | 2.8b | 4.0b | 4.5b |
Revenue growth, % | 43% | 12% | |
Cost of goods sold | 2.2b | 3.0b | 3.5b |
Gross profit | 664.0m | 987.0m | 1.0b |
Gross profit Margin, % | 24% | 24% | 23% |
General and administrative expense | 182.0m | 300.0m | 303.0m |
Operating expense total | 453.0m | 754.0m | 1.6b |
Depreciation and amortization | 167.0m | 330.0m | 374.0m |
Interest expense | 12.0m | 121.0m | 137.0m |
Pre tax profit | 199.0m | 112.0m | (730.0m) |
Income tax expense | (9.0m) | 40.0m | (54.0m) |
Net Income | 208.0m | 72.0m | (676.0m) |
EPS | 1.5 | 0.4 | (4.2) |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 |
---|---|---|---|---|---|---|---|---|
Revenue | 793.0m | 1.1b | 1.1b | 1.1b | 1.2b | 1.1b | 1.1b | 1.1b |
Cost of goods sold | 597.0m | 813.0m | 816.0m | 836.0m | 908.0m | 863.0m | 899.0m | 912.0m |
Gross profit | 196.0m | 255.0m | 259.0m | 271.0m | 264.0m | 263.0m | 209.0m | 230.0m |
Gross profit Margin, % | 25% | 24% | 24% | 24% | 23% | 23% | 19% | 20% |
General and administrative expense | 61.0m | 89.0m | 76.0m | 72.0m | 81.0m | 77.0m | 62.0m | 65.0m |
Operating expense total | 145.0m | 182.0m | 174.0m | 194.0m | 191.0m | 154.0m | 176.0m | 182.0m |
Depreciation and amortization | 64.0m | 74.0m | 76.0m | 101.0m | 90.0m | 92.0m | 96.0m | 96.0m |
Interest expense | 10.0m | 37.0m | 37.0m | 35.0m | 36.0m | 34.0m | 30.0m | 29.0m |
Pre tax profit | 41.0m | 36.0m | 48.0m | 42.0m | 37.0m | 75.0m | 3.0m | 19.0m |
Income tax expense | 12.0m | 12.0m | 10.0m | 11.0m | 8.0m | 22.0m | 6.0m | 3.0m |
Net Income | 29.0m | 24.0m | 38.0m | 31.0m | 29.0m | 53.0m | (3.0m) | 16.0m |
EPS | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 | 0.0 | 0.1 |
USD | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|
Cash | 88.0m | 147.0m | |
Accounts Receivable | 354.0m | 484.0m | 513.0m |
Prepaid Expenses | 74.0m | 141.0m | 81.0m |
Current Assets | 449.0m | 878.0m | 887.0m |
PP&E | 290.0m | 368.0m | 307.0m |
Goodwill | 2.0b | 3.2b | 2.7b |
Total Assets | 3.7b | 6.1b | 5.4b |
Accounts Payable | 195.0m | 246.0m | 218.0m |
Short-term debt | 160.0m | 217.0m | 239.0m |
Current Liabilities | 605.0m | 1.0b | 1.1b |
Long-term debt | 144.0m | 2.5b | 2.4b |
Total Debt | 304.0m | 2.7b | 2.7b |
Total Liabilities | 950.0m | 3.9b | 4.0b |
Common Stock | 2.0m | 2.0m | |
Additional Paid-in Capital | 2.2b | 2.3b | |
Retained Earnings | 2.0m | (713.0m) | |
Total Equity | 2.7b | 2.2b | 1.4b |
Debt to Equity Ratio | 0.1 x | 1.2 x | 2 x |
Debt to Assets Ratio | 0.1 x | 0.4 x | 0.5 x |
Financial Leverage | 1.3 x | 2.8 x | 4 x |
USD | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|
Net Income | 208.0m | 72.0m | (676.0m) |
Depreciation and Amortization | 167.0m | 330.0m | 374.0m |
Accounts Receivable | 49.0m | 102.0m | 97.0m |
Accounts Payable | 113.0m | (18.0m) | 14.0m |
Cash From Operating Activities | 530.0m | 462.0m | 626.0m |
Purchases of PP&E | (18.0m) | (26.0m) | (17.0m) |
Cash From Investing Activities | (34.0m) | (1.3b) | (210.0m) |
Short-term Borrowings | (50.0m) | (150.0m) | |
Long-term Borrowings | (157.0m) | (342.0m) | (234.0m) |
Dividends Paid | (1.0b) | (38.0m) | |
Cash From Financing Activities | (496.0m) | 955.0m | (294.0m) |
Net Change in Cash | 99.0m | 122.0m | |
Interest Paid | 19.0m | 115.0m | 127.0m |
Income Taxes Paid | 11.0m | 61.0m | 32.0m |
USD | FY, 2018 |
---|---|
Revenue/Employee | 366.1k |
Debt/Equity | 0.1 x |
Debt/Assets | 0.1 x |
Financial Leverage | 1.3 x |
FY, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | FY, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | FY, 2020 | Q1, 2021 | Q2, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Backlog | $8.99 b | $10.17 b | $10.43 b | $10.68 b | $10.42 b | $12.70 b | $13.25 b | $13.35 b | $13.52 b | $13.89 b | |
Backlog (Defense and Intelligence) | $1.98 b | $2 b | $1.41 b | $6.64 b | $1.99 b | $1.97 b | $8.06 b | $8.34 b | $8.46 b | $8.59 b | |
Backlog (Civilian and Health Care) | $7.01 b | $8.17 b | $326 m | $4.04 b | $8.53 b | $10.74 b | $5.16 b | $5.01 b | $5.07 b | $5.31 b | |
Contract Awards | $1.32 b | $2.36 b | $1.73 b | $6.80 b | $1 b | $2.31 b | $1.61 b | $6.09 b | $1.18 b | $1.77 b | |
Contract Awards (Defense and Intelligence) | $345 m | $1.70 b | $1.40 b | $4.70 b | $669 m | $1.93 b | $515 m | $3.78 b | $863 m | $1.02 b | |
Contracts Awards (Civilian and Health Care) | $975 m | $664 m | $326 m | $2.10 b | $332 m | $372 m | $1.10 b | $2.31 b | $313 m | $751 m | |
Remaining Performance Obligations | $3.60 b | $3.84 b | |||||||||
Patents Issued | 270 | ||||||||||
New Patents | 17 | ||||||||||
Facility Space, sq. ft. | 1.80 m | 2.70 m | 2.70 m | ||||||||
New Government-Funded Research Projects Launched | 18 | ||||||||||
Medicare Insurance Claims Processed | 665 m | ||||||||||
Office 365 Mailbox Migrations | 90 k | ||||||||||
Interfaces Created | 19 | ||||||||||
Unauthorized Intrusion Attempts Prevented per Year | 2.50 b | 2.50 b | |||||||||
Threats Detected | 300 m | 300 m |